Author(s):
Akashkumar Shah, Khushbu Patel
Email(s):
akashn.shah@zyduswellness.com , aarvipatel85@gmail.com
DOI:
10.52711/0974-360X.2026.00212 
Address:
Akashkumar Shah1, Khushbu Patel2
1Research Scholar, Faculty of Pharmacy, Nootan Pharmacy College, Sankalchand Patel University, Visnagar, Gujarat, India.
2Associate Professor, Faculty of Pharmacy, Nootan Pharmacy College, Sankalchand Patel University, Visnagar, Gujarat, India.
*Corresponding Author
Published In:
Volume - 19,
Issue - 4,
Year - 2026
ABSTRACT:
Objectives: The Quality by Design (QbD) approach validates the formulation during development, ensuring optimization through the meticulous selection of herbal extracts. Methods: Oral dosage forms, particularly fast-dissolving films containing various herbal extracts (such as turmeric, saffron, and ginger), were developed to achieve immediate therapeutic effects. The Quality by Design (QbD) approach emphasizes a science-based methodology in product development. Design of Experiments (DOE) and ANOVA are utilized to analyze high-risk Critical Quality Attributes (CQAs). Design Expert software aids in determining the optimal quantities of variables in the formulation by analyzing the effects of independent variables to establish the design space. Findings: The effects of the identified independent variables, Pullulan and PEG 400, were investigated. Their impact on critical responses, Folding Endurance and Disintegration Time, were analyzed, revealing a significant influence on both responses. The optimized formulation, containing 50 mg/film of Pullulan and 20 mg/film of PEG 400, meets the desired QTPP and Pharmacopoeial standards for fast-dissolving films. ANOVA results indicated p-values of 0.0417 and 0.0448 for the respective variables, confirming the model's significance. The optimized fast-dissolving film (FDF) formulation with three natural extract combinations exhibited a Folding Endurance of 198±1.35 folds and a Disintegration Time (DT) of 35±3.48 kg/cm², which are highly desirable from a formulation perspective. Novelty: The successful creation of a fast-dissolving film containing turmeric, saffron, and ginger using a QbD approach underscores the distinct challenges of formulation compared to other potent APIs. Additionally, achieving the desired folding endurance and disintegration time in a formulation with natural extracts at 17.75% potency is a groundbreaking achievement. There is no existing QbD methodology for a product that integrates three different natural extracts into a fast-dissolving film dosage form. Thus, applying QbD to develop and optimize the formulation and attain the desired outcomes is a significant accomplishment.
Cite this article:
Akashkumar Shah, Khushbu Patel. Development and Optimization of Fast-Dissolving Films Containing Multiple Natural Extracts Using a Quality by Design Approach. Research Journal of Pharmacy and Technology. 2026;19(4):1473-2. doi: 10.52711/0974-360X.2026.00212
Cite(Electronic):
Akashkumar Shah, Khushbu Patel. Development and Optimization of Fast-Dissolving Films Containing Multiple Natural Extracts Using a Quality by Design Approach. Research Journal of Pharmacy and Technology. 2026;19(4):1473-2. doi: 10.52711/0974-360X.2026.00212 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2026-19-4-1
5. REFERENCES:
1. Djuris, Jelena, Svetlana Ibric, and Zorica Đurić. Quality by design in the pharmaceutical development." Computer-aided applications in pharmaceutical technology. Woodhead Publishing, 2024; 1-21. Available from: https://doi.org/10.1016/B978-0-443-18655-4.00003-0
2. Sarwar Beg, Md Saquib Hasnain, Mahfoozur Rahman, Suryakanta Swain. Introduction to Quality by Design (QbD): Fundamentals, Principles, and Applications. Academic Press. 2019; 1-17. Available from: https://doi.org/10.1016/B978-0-12-815799-2.00001-0
3. Benetti, C., Benetti, A.A. Quality by Design in Formulation Development. In: Jain, N.K., Bajwa, N. (eds) Introduction to Quality by Design (QbD). Springer, Singapore. 2024; 139-159 p. https://doi.org/10.1007/978-981-99-8034-5_6
4. Pawar, S. S., Mahale, Y. S., Kalamkar, P. A., Satdive, R. A., Sonawane, S. K., and Bhapkar, S. P. Quality by design (QbD): A comprehensive understanding and implementation in pharmaceuticals development. Current Pharmaceutical Analysis. 2023; 19(9): 677-686. Available from: https://doi.org/10.2174/1573412919666230914103355
5. Chordiya, Mayur Ashok; Gangurde, Hemant Hiraman; Sancheti, Vikram Nirmal. Quality by Design: A Roadmap for Quality Pharmaceutical Products. Journal of Reports in Pharmaceutical Sciences. 2019; 8(2): 289-294. Available from: https://doi.org/10.4103/jrptps.JRPTPS_2_18
6. Darkunde, Sachin L. A review on quality by design. International journal of pharmaceutical chemistry and analysis. 2020; 5(1): 1-6 p. Available from: https://doi.org/10.20959/wjpr202014-19073
7. Edavalath, M., and Bharathan, B. P. Methodology for developing and evaluating diagnostic tools in Ayurveda–a review. Journal of Ayurveda and Integrative Medicine. 2021; 12(2): 389-397 p. Available from: https://doi.org/10.1016/j.jaim.2021.01.009
8. Verma, S. K., Pandey, M., Sharma, A., and Singh, D. Exploring Ayurveda: principles and their application in modern medicine. Bulletin of the National Research Centre. 2024; 48(1): 77 p. Available from: https://doi.org/10.1186/s42269-024-01231-0
9. Chaturvedi S, Kumar NA, Tillu G, Patwardhan B. Research, biomedicine and Ayurveda: From evidence-based medicine to evidence-informed healthcare. Indian Journal of Medical Ethics. 2021; 6(4): 301-305. Available from: https://doi.org/10.4103/0975-9476.90769
10. Mzabri, Ibtissam, Mohamed Addi, Abdelbasset Berrichi. Traditional and modern uses of saffron (Crocus sativus). Cosmetics 2019; 63. Available from: https://doi.org/10.3390/cosmetics6040063
11. Eleonora Hay, Angela Lucariello, Marcella Contieri, Teresa Esposito, Antonio De Luca, Germano Guerrad, Angelica Perna. Therapeutic effects of turmeric in several diseases: An overview. Chemico-biological interactions. 2019; 310: 108729. Available from: https://doi.org/10.1016/j.cbi.2019.108729
12. Kausar, T., Anwar, S., Hanan, E., Yaseen, M., Aboelnaga, S. M., and Azad, Z. R. Therapeutic role of ginger (Zingiber officinale) - A review. Journal of Pharmaceutical Research International. 2021; 33(29B): 9-16 p. Available from: https://doi.org/10.9734/jpri/2021/v33i29B31584
13. Mustafa, I., and Chin, N. L. (2023). Antioxidant properties of dried ginger (Zingiber officinale Roscoe) var. Bentong. Foods. 2023; 12(1): 178 p. Available from: https://doi.org/10.3390/foods12010178
14. Singh, A., Kharb, V., and Saharan, V. A. Fast dissolving/disintegrating dosage forms of natural active compounds and alternative medicines. Recent Patents on Drug Delivery and Formulation. 2020; 14(1): 21-39 p. Available from: https://doi.org/10.2174/1872211314666200324174703
15. Gaonkar, V. P., Mannur, V. S., Mastiholimath, V. S., and Hullatti, K. K. Development and Evaluation of Herbal Supplement: A Quality by Design Approach. Indian Journal of Pharmaceutical Sciences. 2020; 82(4), 640 p. Available from: https://doi.org/10.36468/pharmaceutical-sciences.690
16. Beg, S., Rahman, M., and Kohli, K. Quality-by-design approach as a systematic tool for the development of nanopharmaceutical products. Drug discovery today. 2019; 24(3): 717-725 p. Available from: https://doi.org/10.1016/j.drudis.2018.12.002
17. Pazhayattil, A. B., Sharma, S., Philip, J. P., Gischewski-Silva, M., and Ingram, M. Quality Risk Management (QRM). Technology Transfer: Drug Product Manufacturing Process. Cham: Springer International Publishing, 2023; 29-42 p. Available from: https://doi.org/10.1007/978-3-031-32192-4_3
18. Dhoot, A. S., Fernandes, G. J., Naha, A., Rathnanand, M., and Kumar, L. Design of experiments in pharmaceutical development. Pharmaceutical chemistry journal. 2019; 53: 730-735 p. Available from: https://doi.org/10.1007/s11094-019-02070-4
19. Malviya, V., Thakur, Y., Gudadhe, S. S., and Tawar, M. Formulation and evaluation of natural gum based fast dissolving tablet of Meclizine hydrochloride by using 3 factorial design 2. Asian Journal of Pharmacy and Pharmacology. 2020; 6(2): 94-100. Available from: https://doi.org/10.31024/ajpp.2020.6.2.7
20. Almukainzi, M., Araujo, G. L., and Löbenberg, R. Orally disintegrating dosage forms. Journal of Pharmaceutical Investigation, 2019; 49: 229-243. Available from: https://doi.org/10.1007/s40005-018-0408-2
21. Comoglu, Tansel, and Emine Dilek Ozyilmaz. Pharmaceutical product development: a “quality by design” (QbD) approach. Dosage Forms, Formulation Developments and Regulations. Academic Press, 2024; 285-310 p. Available from: https://doi.org/10.1016/B978-0-323-91817-6.00001-2
22. Subhramanya, A. B. K., Nayak, P., Ramalingappa, H., Hemanna, H. K., and Shetty, P. ICH Q1 a Stability Testing for New Dosage Form. International Journal of Pharmaceutical Investigation, 2024; 14(3): 881–887 p. Available from: https://doi.org/10.5530/ijpi.14.3.98